Silence Therapeutics Plc (SLNCF)
2.00
0.00 (0.00%)
USD |
OTCM |
Mar 20, 16:00
Silence Therapeutics Market Cap : 283.40M for March 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Adaptimmune Therapeutics Plc | 5.301M |
| Biodexa Pharmaceuticals Plc | 0.5877M |
| Oxford Biomedica Plc | 982.08M |
| NuCana Plc | 6.867M |
| Autolus Therapeutics Plc | 364.62M |
Market Cap Related Metrics
| PS Ratio | 506.96 |
| PEG Ratio | -0.2587 |
| Price to Book Value | 4.549 |
| Price | 2.00 |
| Earnings Yield | -31.27% |
| PEGY Ratio | -0.2587 |